Cargando…
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis
BACKGROUND: The prognostic biomarker for patients undergoing curative liver metastasectomy for colorectal cancer (CRC) is lacking. The purpose was to investigate the prognostic role of a lack of CDX2 expression, which has been proposed as a potential biomarker for high-risk relapse in early-stage CR...
Autores principales: | Shigematsu, Yasuyuki, Inamura, Kentaro, Yamamoto, Noriko, Mise, Yoshihiro, Saiura, Akio, Ishikawa, Yuichi, Takahashi, Shunji, Kanda, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192098/ https://www.ncbi.nlm.nih.gov/pubmed/30326864 http://dx.doi.org/10.1186/s12885-018-4902-8 |
Ejemplares similares
-
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan
por: Shigematsu, Yasuyuki, et al.
Publicado: (2018) -
Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor
por: Shigematsu, Yasuyuki, et al.
Publicado: (2017) -
CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
por: Sugawara, Emiko, et al.
Publicado: (2023) -
Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver: Clinical and pathological features
por: Shigematsu, Yasuyuki, et al.
Publicado: (2022) -
Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)